Funding for this research was provided by:
Natural Science Foundation of Jiangsu Province (BK20160575, BK20170592)
the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (19KJB180029, 17KJB180015)
the Open Funding Project of Jiangsu Key Laboratory of Chiral Pharmaceuticals Biosynthesis (SX1702)
the Research Initiation Project of Taizhou University (QD2016037)
Received: 1 November 2020
Accepted: 5 January 2021
First Online: 19 January 2021
Ethics approval and consent to participate
: Not applicable.
: This article does not contain any individual person’s data.
: The authors declare that they have no competing interests.